1. Isoprenoid Biosynthesis as a Drug Target: Bisphosphonate Inhibition of Escherichia coli K12 Growth and Synergistic Effects of Fosmidomycin
2. bSuzuki, F.; Fujikawa, Y.; Yamamoto, S.; Mizutani, H.; Funabashi, C.; Ohya, T.; Ikai, T.; Oguchi, T. Pharmaceutical Compositions Containing Geminal Diphosphonates. U.S. Patent 5,583,122 A, February 1, 1979.
3. aChmielewska, E.; Kempińska, K.; Wietrzyk, J.; Pia̧tek, A.; Kiełbowicz, Z.; Kafarski, P. Novel Bisphosphonates and Their Use. WO Patent 2015159153 A1, October 22, 2015.
4. bSanders, J. M.; Song, Y.; Oldfield, E.; Zhang, Y. Bisphosphonate Compounds and Methods for Bone Resorption Diseases, Cancer, Bone Pain, Immune Disorders, and Infectious Diseases. U.S. Patent 7,358,361 B2, October 8, 2004.
5. Lipophilic Bisphosphonates as Dual Farnesyl/Geranylgeranyl Diphosphate Synthase Inhibitors: An X-ray and NMR Investigation